University of Utah Orthopedics
Welcome,         Profile    Billing    Logout  
 12 Trials 
12 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Miller, Michael
ELSA-2, NCT05128955: Embolization of the Splenic Artery After Trauma

Recruiting
N/A
250
US
Splenic artery embolization with vascular embolic coils or plugs
Andrew J. Gunn, Penumbra Inc.
High-grade Splenic Injuries
04/25
04/25
Lawrence, Brandon
NCT06143956: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Recruiting
2
1040
US, RoW
LY3305677, LY3841136, Tirzepatide, Placebo, LY3549492
Eli Lilly and Company
Obesity, Overweight
06/26
09/26
NCT06603571: A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Recruiting
2
350
US, RoW
LY3841136, Tirzepatide, Placebo
Eli Lilly and Company
Obesity, Overweight
06/26
08/26
NCT06683508: A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight

Recruiting
2
275
US, RoW
LY3549492, Placebo
Eli Lilly and Company
Obesity, Overweight
04/26
09/26
NCT06074562: A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Recruiting
2
410
Europe, Japan, US, RoW
LY3556050, Placebo
Eli Lilly and Company
Diabetic Peripheral Neuropathy
07/25
07/25
NCT05936151: A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Recruiting
2
120
Europe, Canada, US
Retatrutide, LY3437943, Placebo
Eli Lilly and Company
Overweight or Obesity, CKD, Type 2 Diabetes
11/25
11/25
NCT06680375: A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Active, not recruiting
1/2
780
US
Flu Seasonal /SARS-CoV-2 mRNA Dose 1, Flu Seasonal /SARS-CoV-2 mRNA Dose 2, Flu Seasonal mRNA, SARS-CoV-2 mRNA Dose 1, SARS-CoV-2 mRNA Dose 2, Licensed Flu Seasonal, Licensed COVID-19 mRNA, Placebo, Phase 2 selected Investigational Flu Seasonal/SARS-CoV-2 mRNA, Phase 2 selected SARS-CoV-2 mRNA
GlaxoSmithKline
COVID-19
05/25
11/25
Higgins, Thomas
ANCHOR-1, NCT05274750 / 2021-005037-16: Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Hourglass Jul 2024 - Dec 2024 : Acceptance of regulatory submission in US for CRSwNP
Completed
3
276
Europe, Canada, Japan, US, RoW
Depemokimab (GSK3511294), Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Nasal Polyps
07/24
08/24
NCT06019000: Study of CYR-064 Versus Placebo in Patients.

Recruiting
2
150
US
CYR-064
Cyrano Therapeutics, Inc.
Hyposmia
06/25
06/25
NCT06163404: Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant

Recruiting
N/A
50
US
Implantation of Spirair Nasal Device using the Spirair delivery system., SeptAlign
Spirair, Inc
Nasal Septal Deviation, Nasal Airway Obstruction
12/24
07/25
Pelt, Christopher
NCT03737149: A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform

Active, not recruiting
N/A
10500
Europe, US, RoW
mymobility with Apple Watch
Zimmer Biomet
Osteoarthritis, Knee, Osteoarthritis, Hip
12/24
07/25
NCT04754087: G7 Acetabular System with Vivacit-E or Longevity Liner PMCF Study

Recruiting
N/A
300
Europe, US
Vivacit-E and Longevity (HXLPE) Liners
Zimmer Biomet
Total Hip Arthroplasty, Degenerative Joint Disease of Hip, Avascular Necrosis of Hip, Rheumatoid Arthritis of Hip, Osteoarthritis, Hip, Osteoarthritis of Hip, Fractures, Hip, Fracture of Hip
12/33
12/33
Haller, Justin
No trials found
Solis, Victor
No trials found
Spiker, Ryan
No trials found
Olsen, Zachary
No trials found
Joyce, Christopher
No trials found

Download Options